作为治疗帕金森病的免疫调节在当前试验中的治疗:系统性审查和元分析
Vera T Vega-Angeles1, Valeria Morales-Ruiz1, Laura V Adalid-Peralta1
1Laboratorio de Reprogramación Celular, Instituto de Fisiología Celular-Uiversidad Nacional Autónoma de México, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, Mexico.
概括
免疫调节治疗没有改善帕金森病患者的运动症状. 需要对更大的患者群体进行进一步的研究,以探索这些疗法的潜在益处.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 临床试验 临床试验
背景情况:
- 神经炎症是帕金森病 (PD) 发展和进展的关键因素.
- 免疫调节药物和免疫疗法正在研究PD治疗.
- 临床试验正在评估这些新的治疗方法.
研究的目的:
- 审查PD随机对照试验 (RCT) 中免疫调节剂的证据.
- 评估免疫调节剂对运动症状改善的影响.
- 综合最近临床研究的发现.
主要方法:
- 运动障碍学会对帕金森病统一评级表 (MDS-UPDRS III) 的元分析得分.
- 在PubMed,科克伦图书馆和科学网 (2000年至2023年7月) 进行系统搜索.
- 包括七个RCT比较免疫调节剂与安慰剂.
主要成果:
- 590名患者接受了免疫调节剂,622人接受了安慰剂.
- 两组之间MDS-UPDRS III得分变化没有显著差异 (平均差异-0.46,p < 0.01).
- 两项研究表明,随着治疗,运动症状有所改善.
结论:
- 目前的免疫调节疗法在改善PD运动症状方面没有效果.
- 需要进行更大规模的临床试验来最终评估治疗效果.
- 需要进一步的研究来探索帕金森病中的免疫调节.
相关概念视频
01:24Parkinson's Disease: Treatment
244
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
244
01:15Parkinson's Disease: Overview
517
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
517
01:27Tumor Immunotherapy
504
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
504
01:37Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:30Cancer Vaccines
350
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
350